# A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

> **NCT07001280** · — · RECRUITING · sponsor: **CSL Behring** · enrollment: 200 (estimated)

## Conditions studied

- Hereditary Angioedemas

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT07001280
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-21
- **Primary completion:** 2028-08-31
- **Final completion:** 2030-08-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07001280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07001280, "A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT07001280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*